Great Point Partners’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-579,667
Closed -$1.67M 48
2023
Q3
$1.67M Sell
579,667
-1,688,390
-74% -$4.86M 0.3% 38
2023
Q2
$8.64M Sell
2,268,057
-885,149
-28% -$3.37M 1.69% 23
2023
Q1
$5.86M Buy
3,153,206
+1,190,807
+61% +$2.21M 1.15% 27
2022
Q4
$4.51M Buy
1,962,399
+1,513,350
+337% +$3.48M 0.88% 35
2022
Q3
$1.45M Buy
+449,049
New +$1.45M 0.35% 35